Literature DB >> 9035300

Graft damage after a single lung transplantation for pulmonary hypertension in a rat model.

S Yamamoto1, K Kawahara, T Takahashi, S Akamine, T Tagawa, A Nakamura, M Muraoka, S Ide, N Sasaki, H Shingu, T Nagayasu, N Yamasaki, M Tomita.   

Abstract

The hemodynamic effect and degree of damage in grafts of single lung transplants for pulmonary hypertension were studied in rats with monocrotaline-induced pulmonary hypertension. Inbred male Lewis rats (weight 200-230 g) were divided into two groups. Group 1 (control group, n = 16) underwent isogenic left lung transplantation, while group 2 (n = 15) received an intravenous administration of monocrotaline (80 mg/kg i.v.) and underwent isogenic left single lung transplantation 3 week later. Hemodynamic evaluations were performed prior to transplantation, at 1 h postoperatively, and on days 3 and 7 after transplantation. Mean pulmonary arterial pressure (mPAP) rapidly declined after transplantation in group 2, from 39.3 +/- 8.7 mmHg to 18.5 +/- 3.0 mmHg 1 h after transplantation, and remained stable on day 7 after transplantation. No significant difference in the mPAP between the two groups was observed after transplantation. The extravascular lung water volume (ELWV: dry/wet ratio) in the right lung of group 2 significantly increased on day 3 (0.86 +/- 0.02) (P < 0.01), and subsequently decreased to control levels on day 7 (0.83 +/- 0.02). There was no significant difference in the ELWV in the grafted lungs between the two groups (0.84 +/- 0.03 vs 0.86 +/- 0.04), but there was tendency toward an increase in ELWV in group 2 on days 3 and 7. These data thus demonstrated that a hemodynamic improvement was obtained by single lung transplantation; however the degree of graft damage was remarkable in the pulmonary hypertension group.

Entities:  

Mesh:

Year:  1997        PMID: 9035300     DOI: 10.1007/bf01366939

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  18 in total

1.  The distribution of ventilation and perfusion after single-lung transplantation in patients with pulmonary fibrosis and pulmonary hypertension.

Authors:  M R Kramer; S E Marshall; I R McDougall; A Kloneck; V A Starnes; N J Lewiston; J Theodore
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  Single-lung transplantation for pulmonary vascular disease.

Authors:  J R Maurer; T L Winton; G A Patterson; T R Williams
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Arterial changes in Crotalaria spectabilis-induced pulmonary hypertension in rats.

Authors:  A Hislop; L Reid
Journal:  Br J Exp Pathol       Date:  1974-04

4.  Toxicity of pyrrolizidine alkaloids.

Authors:  A R Mattocks
Journal:  Nature       Date:  1968-02-24       Impact factor: 49.962

5.  Selection and evaluation of recipients for heart-lung and lung transplantation.

Authors:  S E Marshall; M R Kramer; N J Lewiston; V A Starnes; J Theodore
Journal:  Chest       Date:  1990-12       Impact factor: 9.410

6.  Lung reperfusion in dogs causes bilateral lung injury.

Authors:  M J Bishop; E Y Chi; F W Cheney
Journal:  J Appl Physiol (1985)       Date:  1987-09

7.  Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung.

Authors:  W M Lafranconi; R J Huxtable
Journal:  Biochem Pharmacol       Date:  1984-08-01       Impact factor: 5.858

8.  Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity.

Authors:  A R Mattocks; I Bird
Journal:  Chem Biol Interact       Date:  1983-02       Impact factor: 5.192

9.  The conversion of pyrrolizidine alkaloids to N-oxides and to dihydropyrrolizine derivatives by rat-liver microsomes in vitro.

Authors:  A R Mattocks; I N White
Journal:  Chem Biol Interact       Date:  1971-10       Impact factor: 5.192

10.  Single lung transplantation in rats with chemically induced pulmonary hypertension.

Authors:  A T Kawaguchi; T Mizuta; H Matsuda; R Shirakura; K Nakahara; H Tanaka; Y Kawashima
Journal:  J Thorac Cardiovasc Surg       Date:  1992-03       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.